αCGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors

Significance Pain is a societal burden with enormous economic and social costs. More than 50% of pain patients find current therapies unsatisfactory. A major reason for this pharmacological failure is our limited understanding of the cellular processes underlying pain. Algesic sensitization of nociceptors is a complex event in pain transduction that involves the potentiation of thermosensory channels. The molecular mechanisms remain controversial because of nociceptor heterogeneity that suggests the existence of cell-type–specific strategies. We show that algesic sensitization of transient receptor potential vanilloid 1 (TRPV1) involves the exocytotic recruitment of new receptors in peptidergic nociceptors and the modulation of channel gating in nonpeptidergic sensory neurons. Furthermore, algesic delivery of TRPV1 channels is concomitant with pro-inflammatory neuropeptide secretion, ensuring rapid modulation of pain transduction. Proalgesic sensitization of peripheral nociceptors in painful syndromes is a complex molecular process poorly understood that involves mobilization of thermosensory receptors to the neuronal surface. However, whether recruitment of vesicular thermoTRP channels is a general mechanism underlying sensitization of all nociceptor types or is subtype-specific remains controversial. We report that sensitization-induced Ca2+-dependent exocytotic insertion of transient receptor potential vanilloid 1 (TRPV1) receptors to the neuronal plasma membrane is a mechanism specifically used by peptidergic nociceptors to potentiate their excitability. Notably, we found that TRPV1 is present in large dense-core vesicles (LDCVs) that were mobilized to the neuronal surface in response to a sensitizing insult. Deletion or silencing of calcitonin-gene–related peptide alpha (αCGRP) gene expression drastically reduced proalgesic TRPV1 potentiation in peptidergic nociceptors by abrogating its Ca2+-dependent exocytotic recruitment. These findings uncover a context-dependent molecular mechanism of TRPV1 algesic sensitization and a previously unrecognized role of αCGRP in LDCV mobilization in peptidergic nociceptors. Furthermore, these results imply that concurrent secretion of neuropeptides and channels in peptidergic C-type nociceptors facilitates a rapid modulation of pain signaling.

[1]  Keivan Basiri,et al.  The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy , 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[2]  Ya-Yun Wang,et al.  A closer look to botulinum neurotoxin type A-induced analgesia. , 2013, Toxicon : official journal of the International Society on Toxinology.

[3]  M. Zylka,et al.  Peptidergic CGRPα Primary Sensory Neurons Encode Heat and Itch and Tonically Suppress Sensitivity to Cold , 2013, Neuron.

[4]  V. Felipo,et al.  An Inhibitor of Neuronal Exocytosis (DD04107) Displays Long-Lasting In Vivo Activity against Chronic Inflammatory and Neuropathic Pain , 2012, Journal of Pharmacology and Experimental Therapeutics.

[5]  D. J. Cavanaugh,et al.  Restriction of Transient Receptor Potential Vanilloid-1 to the Peptidergic Subset of Primary Afferent Neurons Follows Its Developmental Downregulation in Nonpeptidergic Neurons , 2011, The Journal of Neuroscience.

[6]  J. González-Ros,et al.  Role of the transient receptor potential vanilloid 1 in inflammation and sepsis , 2011, Journal of inflammation research.

[7]  Xu Zhang,et al.  Transport of receptors, receptor signaling complexes and ion channels via neuropeptide-secretory vesicles , 2011, Cell Research.

[8]  H. Diener,et al.  OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial , 2010, Cephalalgia : an international journal of headache.

[9]  H. Diener,et al.  OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial , 2010, Cephalalgia : an international journal of headache.

[10]  Manuela Schmidt,et al.  Nociceptive Signals Induce Trafficking of TRPA1 to the Plasma Membrane , 2009, Neuron.

[11]  A. Ferrer-Montiel,et al.  Differential contribution of SNARE‐dependent exocytosis to inflammatory potentiation of TRPV1 in nociceptors , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  S. Ovsepian,et al.  Activation of TRPV1 Mediates Calcitonin Gene-Related Peptide Release, Which Excites Trigeminal Sensory Neurons and Is Attenuated by a Retargeted Botulinum Toxin with Anti-Nociceptive Potential , 2009, The Journal of Neuroscience.

[13]  H. Koerber,et al.  Thermal nociception and TRPV1 function are attenuated in mice lacking the nucleotide receptor P2Y2 , 2008, PAIN.

[14]  S. Jung,et al.  Differential Changes in TRPV1 expression after trigeminal sensory nerve injury. , 2008, The journal of pain : official journal of the American Pain Society.

[15]  M. Pauza,et al.  Direct Role of Streptozotocin in Inducing Thermal Hyperalgesia by Enhanced Expression of Transient Receptor Potential Vanilloid 1 in Sensory Neurons , 2008, Molecular Pharmacology.

[16]  R. Ji,et al.  Neurokinin-1 Receptor Enhances TRPV1 Activity in Primary Sensory Neurons via PKCε: A Novel Pathway for Heat Hyperalgesia , 2007, The Journal of Neuroscience.

[17]  C. M. Flores,et al.  Critical evaluation of the colocalization between calcitonin gene-related peptide, substance P, transient receptor potential vanilloid subfamily type 1 immunoreactivities, and isolectin B4 binding in primary afferent neurons of the rat and mouse. , 2007, The journal of pain : official journal of the American Pain Society.

[18]  P. Anand,et al.  Burning mouth syndrome as a trigeminal small fibre neuropathy: Increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score , 2007, Journal of Clinical Neuroscience.

[19]  N. Ziv,et al.  Assembly of Active Zone Precursor Vesicles , 2006, Journal of Biological Chemistry.

[20]  P. McNaughton,et al.  NGF rapidly increases membrane expression of TRPV1 heat‐gated ion channels , 2005, The EMBO journal.

[21]  K. Bölcskei,et al.  Role of Transient Receptor Potential Vanilloid 1 Receptors in Adjuvant-Induced Chronic Arthritis: In Vivo Study Using Gene-Deficient Mice , 2005, Journal of Pharmacology and Experimental Therapeutics.

[22]  N. Carruthers,et al.  Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain , 2005, The Journal of Neuroscience.

[23]  J. Changeux,et al.  Analysis of the cellular expression pattern of β‐CGRP in α‐CGRP‐deficient mice , 2004, The Journal of comparative neurology.

[24]  A. Ferrer-Montiel,et al.  Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor Activity* , 2004, Journal of Biological Chemistry.

[25]  P. McNaughton,et al.  Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor , 2003, The Journal of physiology.

[26]  T. Fukuoka,et al.  Possible Involvement of P2Y2 Metabotropic Receptors in ATP-Induced Transient Receptor Potential Vanilloid Receptor 1-Mediated Thermal Hypersensitivity , 2003, The Journal of Neuroscience.

[27]  N. Ziv,et al.  Unitary Assembly of Presynaptic Active Zones from Piccolo-Bassoon Transport Vesicles , 2003, Neuron.

[28]  J. Simpson,et al.  Glial Cell Line-Derived Neurotrophic Factor is a Survival Factor for Isolectin B4-Positive, but not Vanilloid Receptor 1-Positive, Neurons in the Mouse , 2002, The Journal of Neuroscience.

[29]  M. Masu,et al.  Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Eckart D. Gundelfinger,et al.  Assembling the Presynaptic Active Zone A Characterization of an Active Zone Precursor Vesicle , 2001, Neuron.

[31]  T. Sugimoto,et al.  VR1-immunoreactive primary sensory neurons in the rat trigeminal ganglion , 2001, Brain Research.

[32]  K. Westlund,et al.  Arthritic calcitonin/α calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity , 2001, Pain.

[33]  Jerilyn A. Walker,et al.  Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). , 2000, BioTechniques.

[34]  A I Basbaum,et al.  Impaired nociception and pain sensation in mice lacking the capsaicin receptor. , 2000, Science.

[35]  J. Changeux,et al.  Modulation of morphine analgesia in αcgrp mutant mice , 1999 .

[36]  R. Elde,et al.  Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites , 1999, The European journal of neuroscience.

[37]  A. Basbaum,et al.  The Cloned Capsaicin Receptor Integrates Multiple Pain-Producing Stimuli , 1998, Neuron.

[38]  C. Epstein,et al.  Primary afferent tachykinins are required to experience moderate to intense pain , 1998, Nature.

[39]  H Bostock,et al.  Low-threshold, persistent sodium current in rat large dorsal root ganglion neurons in culture. , 1997, Journal of neurophysiology.

[40]  W. Han,et al.  Calcium sensing in exocytosis. , 2012, Advances in experimental medicine and biology.

[41]  F. Qin,et al.  Complex regulation of TRPV1 and related thermo-TRPs: implications for therapeutic intervention. , 2011, Advances in experimental medicine and biology.

[42]  Antonio Ferrer-Montiel,et al.  Physiology and pharmacology of the vanilloid receptor. , 2006, Current neuropharmacology.

[43]  D. Julius,et al.  The vanilloid receptor: a molecular gateway to the pain pathway. , 2001, Annual review of neuroscience.

[44]  J. Changeux,et al.  Modulation of morphine analgesia in alphaCGRP mutant mice. , 1999, Neuroreport.